Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- McNeil Benylin Ad Encourages Workers to Call in Sick; Employers Hate It
- McNeil Healthcare has posted a series of scripts on a web site for cold medicine Benylin that workers can use to call in sick. A British employers' organization is furious that the drug company, a unit of Johnson & Johnson, is encouraging staff to stay home during the recession. ...
- Blog posts 2009-01-07
Additional Resources
- McNeil Consumer Healthcare Continues To Meet with FDA To Discuss Benecol-R-
- FT. WASHINGTON, Pa.--BUSINESS WIRE--November 6, 1998--McNeil Consumer Healthcare met late yesterday with the Food and Drug Administration FDA to discuss Benecol, the company's new cholesterol-lowering product. The meeting was productive. McNeil Consumer Healthcare presented new scientific information and revised labeling.
- Research articles 1998-11-06
- Johnson & Johnson's McNeil and Takeda Announce Strategic Alliance to Market OTC Products in Japan
- TOKYO--BUSINESS WIRE--Sept. 18, 1997--Johnson & Johnson's (NYSE:JNJ) McNeil Consumer Products Company McNeil and Takeda Consumer Healthcare Company, a division of Takeda Chemical Industries, Ltd., (NIKKEI:TAKEDA), announced today an alliance to market non-prescription healthcare products in Japan.
- Research articles 1997-09-18
- Diagnostic prognostic: Bob Kondraske, Omron Healthcare
- [ILLUSTRATION OMITTED] Omron Healthcare in February tapped Bob Kondraske as its chief operating officer, bringing an executive with consumer packaged goods and OTC products experience, from McNeil Consumer Healthcare, into the diagnostics arena. Drug Store News caught up with Kondraske recently to talk about how his experience with OTC...
- Research articles 2008-06-23
- Top Healthcare, Pharmaceutical Executives Selected as Featured Speakers at RFIDSystems
- NEWTON, Mass. -- MIT, Johnson & Johnson, Ortho-McNeil and EPCglobal among the Industry Leaders to Address Current and Future Applications for RFID and Automatic Identification Systems Advanstar Technology Group today announced the keynote and plenary session speakers for RFIDSystems, May 18-19, 2005, at the Pennsylvania Convention Center in...
- Research articles 2005-03-15
- OTC drug makers seek FDA approval of generic Claritin
- * While the FDA continues to ponder the legalities of a forced over-the-counter OTC switch for Schering-Plough's Claritin loratadine, Aventis' Allegra fexofenadine HCl, and Pfizer's Zyrtec cetirizine HCI, McNeil Consumer Healthcare and Whitehall-Robins Healthcare are trying to circumvent the controversy by filing marketing applications with the FDA for generic OTC...
- Research articles 2002-03-01
- J&J to Slash 7,000 to 8,000 Jobs
- By Ransdell PiersonNEW YORK (Reuters) - Johnson & Johnson plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday.J&J said the planned restructuring will eliminate...
- News items 2009-11-03
- J&J Slashing Workforce
- By Ransdell PiersonNEW YORK (Reuters UK) - Johnson & Johnson JNJ plans to cut up to 7 percent of its workforce in order to generate cost savings needed to finance increasingly costly drug research and to weather future challenges, the diversified healthcare company said on Tuesday.J&J said the planned restructuring...
- News items 2009-11-03
- FDA Approves Second Anti-Cholesterol Spread
- Two weeks after the approval of an anti-cholesterol spread, FDA approved a similar spread this time made by McNeil Consumer Healthcare, clearing the way for marketing in the United States. The spread, called Benecol, contains plant stanol esters that are proven to lower LDL or "bad" cholesterol when used in...
- Research articles 1999-05-24
- Allergan Announces Commercialization Collaboration With McNeil Consumer Healthcare
- IRVINE, Calif.--BW HealthWire--Sept. 14, 1999--
- Research articles 1999-09-14
- Allstate Life Insurance Company Participates in PREPARE Study to Evaluate New Medical Technology
- NORTHBROOK, Ill. -- Allstate teams up with IMI and McNeil Consumer Healthcare for non-invasive risk assessments
- Research articles 2005-08-02
- CorNet Sets World Speed Record for the Fastest Rollout in Sales Force Automation History
- STROUDSBURG, Pa.--BUSINESS WIRE--Dec. 7, 1998-- McNeil Consumer Healthcare Completes National Rollout of CorNet Catalyst Only 16 Weeks After Initiating Requirements Gathering Process CorNet International, Ltd., a leading innovator of vertical-industry sales force automation solutions, Monday announce requirements gathering to complete rollout of avices, Hardware Repair and...
- Research articles 1998-12-07
- Wired to Win: Surviving the Tour de France.(Movie review)
- (DOCU--IMAX) A Partners Healthcare production with support from the National Science Foundation and Ortho-McNeil Neurologics. Produced by JoAnna Baldwin Mallory. Executive producer, Allen Peckham. Directed by Bayley Silleck. Written by Silleck, Daniel Ferguson; story concept, Peter Frumkin....
- Research articles 2006-04-03
- Wired to Win: surviving the Tour de France.(Movie review)
- (Docu--IMAX) A Partners Healthcare production with support from the National Science Foundation and Ortho-McNeil Neurologics. Produced by JoAnna Baldwin Mallory. Executive producer, Allen Peckham. Directed by Bayley Silleck. Written by Silleck, Daniel Ferguson; story concept, Peter Frumkin....
- Research articles 2006-04-03
- Pennsylvania hospital to get new lease on life when it reopens as a cancer specialty hospital.(CTCA Philadelphia reopens)(Brief Article)
- The former Parkview Hospital, Philadelphia, 200 beds, closed by Tenet Healthcare Corp. in 2003, will reopen as a cancer specialty hospital. Now owned by Cancer Treatment Centers of America CTCA, the new hospital will be named CTCA Philadelphia, with John T. McNeil as ...
- Research articles 2005-08-01
- Ocular Sciences Appoints Stephen J. Fanning President and Chief Executive Officer
- Business Editors CONCORD, Calif.--BUSINESS WIRE--Aug. 14, 2001 Ocular Sciences, Inc. (Nasdaq:OCLR) today announced the appointment of Stephen J. Fanning, 50, as President, Chief Executive Officer and member of the Board of Directors. Fanning joins Ocular from Johnson & Johnson (NYSE:JNJ), one of the world's largest manufacturers of healthcare...
- Research articles 2001-08-14
- Zyrtec and Claritin's New Eye Drops Contain Neither Zyrtec Nor Claritin
- There's a strange war brewing between Johnson & Johnson's McNeil Consumer Healthcare unit and Schering-Plough Both companies have extended their Zyrtec and Claritin brands into new eye-drops products, but neither brand contains any of the drugs known as Zyrtec or Claritin. by Jim Edwards
- Blog posts 2009-08-19
- Cypress Pharmaceutical, Inc. receives FDA approval of Cetirizine Hydrochloride Oral Solution
- MADISON, Miss. -- Cypress Pharmaceutical, Inc., announced today that the U.S. Food and Drug Administration FDA has granted final approval of the company's abbreviated new drug application ANDA for the prescription and over-the-counter versions of Cetirizine Hydrochloride Oral Solution, 1 mg/1 mL. Cypress' Cetirizine HCl Oral Solution is the...
- Research articles 2008-10-15
- << Previous
- page 1 of 1
- Next >>
